Hanson & Doremus Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30
| Closed | -$3K | – | 528 |
|
|
2021
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 402 |
|
|
2021
Q1 | $7K | Hold |
30
| – | – | ﹤0.01% | 419 |
|
|
2020
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 423 |
|
|
2020
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 402 |
|
|
2020
Q2 | $4K | Sell |
30
-45
| -60% | -$5.11K | ﹤0.01% | 415 |
|
|
2020
Q1 | $7K | Buy |
75
+45
| +150% | +$4.76K | ﹤0.01% | 403 |
|
|
2019
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 437 |
|
|
2019
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 440 |
|
|
2019
Q2 | $5K | Hold |
30
| – | – | ﹤0.01% | 449 |
|
|
2019
Q1 | $5K | Hold |
30
| – | – | ﹤0.01% | 428 |
|
|
2018
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 425 |
|
|
2018
Q3 | $5K | Hold |
30
| – | – | ﹤0.01% | 433 |
|
|
2018
Q2 | $4K | Hold |
30
| – | – | ﹤0.01% | 467 |
|
|
2018
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 493 |
|
|
2017
Q4 | $4K | Hold |
30
| – | – | ﹤0.01% | 471 |
|
|
2017
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 469 |
|
|
2017
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 468 |
|
|
2017
Q1 | $4K | Hold |
30
| – | – | ﹤0.01% | 451 |
|
|
2016
Q4 | $3.35K | Hold |
30
| – | – | ﹤0.01% | 435 |
|
|
2016
Q3 | $4K | Hold |
30
| – | – | ﹤0.01% | 418 |
|
|
2016
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 421 |
|
|
2016
Q1 | $2K | Buy |
+30
| New | +$1.65K | ﹤0.01% | 444 |
|